The RANK/RANKL axis controls vascular dynamics in the bone marrow
Receptor activator of nuclear factor kappa B ligand (RANKL) is an essential cytokine that induces osteoclastic differentiation by monocyte-macrophage lineage precursors. Here, we showed that in addition to its conventional action, RANKL controls vascular permeability in the bone marrow, where it facilitates the mobilization of hematopoietic monocytic cells, including osteoclast precursors, and resultantly regulates bone metabolism. RANK, a cognate receptor for RANKL, is abundantly expressed in sinusoidal endothelial cells and controls vascular permeability by regulating the expression patterns of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1. High RANKL expression was detected in perivascular C-X-C motif chemokine ligand 12-abundant reticular (CAR) stromal cells. Specific deletion of RANKL expression in CAR cells abrogated the vascular leakage, suggesting that perivascular RANKL is responsible for controlling permeability. In summary, our study revealed a role for RANK/RANKL signaling as a gatekeeper of bone marrow sinusoids in vivo.
Authors
- Daisuke Okuzaki (ORCID: https://orcid.org/0000-0002-4552-783X)
- Junichi Kikuta (ORCID: https://orcid.org/0000-0002-1549-5961)
- Yoshiki Omatsu (ORCID: https://orcid.org/0000-0002-6212-0441)
- Takao Sudo
- Shinya Yari (ORCID: https://orcid.org/0000-0001-7915-5926)
- Kunimaro Furuta (ORCID: https://orcid.org/0000-0001-6440-5929)
- Atsushi Kumanogoh (ORCID: https://orcid.org/0000-0003-4749-7117)
- Kentaro Fujii (ORCID: https://orcid.org/0000-0002-3692-493X)
- Nobuyuki Udagawa (ORCID: https://orcid.org/0000-0002-4075-8698)
- Yoshiaki Kubota (ORCID: https://orcid.org/0000-0001-6672-4122)
- Shigeru Kikuchi
- Shigeto Seno (ORCID: https://orcid.org/0000-0003-3861-6444)
- Kazuma Sato
- Kosuke Muraoka
- Yoshiaki Okada (ORCID: https://orcid.org/0000-0002-2962-244X)
- Yasuhiro Kobayashi (ORCID: https://orcid.org/0000-0002-0903-3226)
- Masaru Ishii (ORCID: https://orcid.org/0000-0002-4215-007X)
- Josef Penninger (ORCID: https://orcid.org/0000-0002-8194-3777)
- Qianqian Guo (ORCID: https://orcid.org/0000-0003-4968-7782)
- Samar H. Ibrahim (ORCID: https://orcid.org/0000-0001-8470-8337)
- Takashi Nagasawa (ORCID: https://orcid.org/0000-0002-1085-0960)
- Tetsuo Hasegawa (ORCID: https://orcid.org/0000-0001-7737-9491)
- Takeshi Kaneko (ORCID: https://orcid.org/0009-0005-3576-7679)
Institutions
- University of British Columbia (CA)
- Keio University (JP)
- Ube Frontier University (JP)
- Osaka City University (JP)
- National Institute of Biomedical Innovation, Health and Nutrition (JP)
- Helmholtz Centre for Infection Research (DE)
- Mayo Clinic in Arizona (US)
- Open Medicine Institute (US)
- Osaka International University (JP)
- Medical University of Vienna (AT)
- Osaka University of Pharmaceutical Sciences (JP)
- Matsumoto Dental University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1073/pnas.2425366122
- Citations
- 2
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.61